Molecular characteristics of HIV type 1 circulating in São Paulo, Brazil

AIDS Research and Human Retroviruses

Volumn 21, Issue 7, 2005, Pages 673-682

  Brígido, Luis Fernando De Macedo ^a,b,g   Franco, Heitor M ^a   Custódio, Renata M ^a   Oliveira, Carmen A F ^a   Ferreira, João Leandro P ^a   Eira, Margareth ^c   Bergel, Fernando ^d   Araújo, Fabio ^e   Carvalheiro, Jose R ^f   Rodrigues, Rosangela ^a  

^a Instituto Adolf Lutz   (Brazil)

^b MINISTÉRIO DA SAÚDE   (Brazil)

^c INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^d DST/HIV/Aids Reference Center   (Brazil)

^e DST/HIV/Aids Reference and Training Center   (Brazil)

^f Health State Agency of São Paulo   (Brazil)

^g Laboratório de Retrovirus   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COMPLEMENTARY DNA; GAG PROTEIN; POL PROTEIN; PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ARTICLE; BRAZIL; EPIDEMIC; GENE MUTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNINDEXED SEQUENCE; VIRUS RESISTANCE;

AMINO ACID SEQUENCE; BASE SEQUENCE; BRAZIL; DNA PRIMERS; FEMALE; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENE PRODUCTS, POL; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 23644442569     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.673     Document Type: Article

References (34)

1. Sabino EC, Diaz RS, Brigido LF, et al.: Distribution of HIV-1 subtypes seen in an AIDS clinic in São Paulo City, Brazil. AIDS 1996; 10(13):1579-1584.
2. Russell KL, Carcamo C, Watts DM, et al.: Emerging genetic diversity of HIV-1 in South America. AIDS 2000;18;14(12):1785-1791.
3. Bongertz V, Bou-Habib DC, Brigido LF, et al.: HIV-1 diversity in Brazil: Genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV Isolation and Characterization. J Acquir Immune Defic Syndr 2000;23(2):184-193.
4. Carr JK, Avila M, Gomez Carrillo M. et al.: Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 2001;19(15):F41-47.
5. Thomson MM, Delgado E, Herrero I, et al.: Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. J Gen Virol 2002;83(Pt. 1):107-119.
6. Ministry of Health, Brazil: AIDS Epidemiological Bulletin 1993: VI, issue 12.
7. Ministry of Health. Brazil: AIDS Epidemiological Bulletin 2003; XVII, issue 1.
8. Avila MM, Pando MA, Carrion G, et al.: Two HIV-1 epidemics in Argentina: Different genetic subtypes associated with different risk groups. J Acquir Immune Defic Syndr 2002;29(4):422-426.
9. Velarde-Dunois KG, Guimaraes ML, La Fuente C, et al.: Molecular characterization of human immunodeficiency virus type 1-infected individuals from Bolivia reveals the presence of two distinct genetic subtypes B and F. AIDS Res Hum Retroviruses 2000; 16(17):1921-1926.
10. Gadelha SR, Shindo N, Cruz JN, et al.: Molecular epidemiology of human immunodeficiency virus-1 in the state of Ceara, Northeast, Brazil. Mem Inst Oswaldo Cruz 2003;98(4):461-463.
11. Janssen RS, Satten GA, Stramer SL, et al.: New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;280:42-48.
12. Tanuri A, Vicente AC, Otsuki K, Ramos CA, Ferreira OC, Jr, Schlechter M, et al.: Genetic variation and susceptibilities to protease inhibitors among subtypes B and F isolates in Brazil. Antimicrob Agents Chemother 1999;43:253-258.
13. WHO-UNAlDS: Guidelines for Standard HIV Isolation and Characterization Procedures. 2nd ed., 2002.
14. Thompson J, Higgins D, and Gibson T: Clustal W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight choice. Nucleic Acid Res 1994;22:4673-4680.
15. Saitou N and Nei M: The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 1987;74: 406-425.
16. Kimura M: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980;16(2):111-120.
17. Swofford D: PAUP 4.0: Phylogenetic analysis with parsimony (and other methods), version 4.0b2a. Sinauer Associates Inc., Sunderland, MA, 1999.
18. Page RD: TreeView: An amplification to display phylogenetic trees on personal computers. Comput Appl Biosci 1996;12:357-358.
19. Salminen MO, Carr JK, Burke DS, et al.: Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 1995;11:1423-1425.
20. Posada DK and Crandall A: MODELTEST: Testing the model of DNA substitution. Bioinformatics 1998;14:817-818.
21. D'Aquila RT, Shapiro JM, Brun-Vézinet F, et al.: Drug resistance mutation in HIV-1. Top HIV Med 2002;10:21-25.
22. Gonzales MJ, Machekano RN, and Shafer RW: Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: Classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population. J Infect Dis 2001;184: 998-1006.
23. Briones C, Perez-Olmeda M, Rodriguez C, et al.: Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid. J Acquir Immune Defic Syndr 2001;26(2): 145-150.
24. Ristig MB, Arens MQ, Kennedy M, et al.: Increasing prevalence of resistance mutations in antiretroviral-naive individuals with established HIV-1 infection from 1996-2001 in St. Louis. HIV Clin Trials 2002;3(2):155-160.
25. Mendoza C, Romero J, Rodriguez C, et al.: Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid. AIDS 2002;6;16(13):1830-1832.
26. Sullivan PS, Buskin SE, Turner JH, et al.: Low prevalence of antiretroviral resistance among persons recently infected with human immunodeficiency virus in two US cities. Int J STD AIDS 2002; 13(8):554-558.
27. Chaix ML, Descamps D, Harzic M, et al.: Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS 2003;17(18):2635-2643.
28. Ammaranond P, Cunningham P, Oelrichs R, et al.: Rates of transmission of antiretroviral drug resistant strains of HIV-1. J Clin Virol 2003;26(2):153-161.
29. Bezemer D, Jurriaans S, Prins M, et al.: Declining trend in transmission of drug-resistant HIV-1 in Amsterdam. AIDS 2004;18: 1571-1577.
30. Brindeiro RM, Diaz RS, Sabino EC, et al.: Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): A survey of chronically infected individuals. AIDS 2003;17(7):1063-1069.
31. Barreto CC, Nishiya AS, Busch MP, et al.: HIV subtype and drug resistance among recent and long-standing infected blood donors from São Paulo, Brazil. 11 CROI, Poster 842, 2004.
32. Sucupira MCA, Tescarollo G, Janini M, et al.: High levels of primary antiretroviral genotipic resistance and B/F recombinants in Santos SP, Brazil. 11 CROI, Poster 676, 2004.
33. Holmes EC: Molecular clocks and the puzzle of RNA virus origins. J Virol 2003;77(7):3893-3897.
34. Liu, SL Mittler JE, Nickle DC, et al.: Selection for human immunodeficiency virus type 1 recombinants in a patient with rapid progression to AIDS. J Virol 2002;76:10674-10684.